Rapid Dose Therapeutics to go public on the Canadian Securities Exchange (CSE) through RTO transaction with ACME Resources
Lumira Capital rebranded as Lumira Ventures and launched new website
Sensient Technologies acquired Natural Products Canada (NPC) backed Mazza Innovation Ltd., a global leader in botanical extraction technology
Privateer Holdings owned Tilray to issue 9M Subordinate Voting shares at US $14-$16 per share for proceeds of up to US $144M, with a fully diluted valuation between US $1.41-1.61 billion.
Ample Organics closed Series A round of financing with Osmington Inc., Green Acre Capital, and Canadian and international private investors
Ziliomics, a company created by Fight Against Cancer Innovation Trust (FACIT), secured seed funding from Prospects Oncology Fund, a fund managed by FACIT.
Boulder, Colorado based Stanley Brothers to go public on the Canadian Securities Exchange (CSE) with Canaccord Genuity Corp. acting as sole bookrunner
Privateer Holdings controlled Tilray filed for initial public offering (IPO) on NASDAQ
Precision NanoSystems recently closed US $6M Series B with existing investors 5AM Ventures, Telegraph Hill Partners, Rising Tide Fund, and others.
SoundBite Medical Solutions secured $5.2M Series A add-on led by an Asian investor, bringing total funding of Fidelity Investments Canada led Series A to $25M
Aptose Biosciences (NASDAQ: APTO; TSX: APS) entered into US $20M common share purchase agreement with Chicago based Aspire Capital Fund, LLC.
Tetra Bio-Pharma (TSX-V: TBP; OTCQB: TBPMF) backed North Bud Farms to go public on the Canadian Securities Exchange (CSE).